Gianluigi Reda

18PUBLICATIONS
102CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 29, 2023
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò

|Jun 29, 2023
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.

Andrea Visentin, Francesca Romana Mauro, Lydia Scarfò

|Jun 09, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).

Esther Natalie Oliva, Marta Riva, Pasquale Niscola

|Apr 17, 2023
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.

Fortunato Morabito, Giovanni Tripepi, Francesca Romana Mauro

|Feb 22, 2023
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.

Riccardo Bomben, Francesca Maria Rossi, Filippo Vit

|Nov 09, 2022
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.

Shai Levi, Yotam Bronstein, Neta Goldschmidt

Pageof 3

Frequent Collaborators

10 joint publications

Francesca Romana Mauro

10 joint publications

Luca Laurenti

9 joint publications

Andrea Visentin

5 joint publications

Massimo Gentile